GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
99.23
+4.59 (4.85%)
Sep 16, 2026, 2:15 PM EDT - Market open
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $2.96 billion as of September 16, 2026. Its market cap has decreased by -16.89% in one year.
Market Cap
2.96B
Enterprise Value
2.99B
1-Year Change
-16.89%
Ranking
Category
Stock Price
$99.23
ChartMarket Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $2.96B, a decrease of -83.47%. That is a compound annual growth rate of -26.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 2.68B | -28.81% |
| Dec 31, 2025 | 3.76B | 78.04% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RadNet | 6.07B |
| Sotera Health Company | 5.42B |
| BillionToOne | 4.92B |
| Adaptive Biotechnologies | 4.26B |
| GRAIL | 3.39B |
| Veracyte | 3.23B |
| CareDx | 2.72B |
| NeoGenomics | 2.43B |